Abstract
ABO hemolytic disease of fetus and newborn (ABO-HDFN) occurs almost exclusively in infants of blood group A or B who are born to group O mothers because IgG anti-A or -B occurs more commonly in group O than in group A or B individuals. We report a case of clinically significant ABO-HDFN where the mother was blood group O with elevated IgG anti-A and anti-B titers and delivered a child with an A2B phenotype. This unusual ABO constellation between mother and infant was based on the inheritance of a rare ABO allele encoding for a glycosyltransferase capable of synthesizing both A and B antigens. Because both anti-A and anti-B antibodies may have been involved in hemolysis in this case, it may be relevant to consider the cisAB phenomenon when monitoring ABO-incompatible pregnancies and births.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
ABO Blood-Group System / immunology*
-
Adult
-
Alleles
-
Asian People / genetics
-
Blood Grouping and Crossmatching
-
Erythroblastosis, Fetal / blood
-
Erythroblastosis, Fetal / etiology*
-
Erythroblastosis, Fetal / immunology
-
Female
-
Humans
-
Immunoglobulin G / blood
-
Immunoglobulin G / immunology
-
Infant, Newborn
-
Isoantibodies / blood
-
Isoantibodies / immunology
-
Isoantigens / immunology*
-
Jaundice, Neonatal / etiology*
-
Male
-
Maternal-Fetal Exchange
-
Oligosaccharides / immunology*
-
Oligosaccharides, Branched-Chain
-
Parity
-
Pedigree
-
Phenotype
-
Pregnancy
-
Trisaccharides / immunology*
Substances
-
ABO Blood-Group System
-
Immunoglobulin G
-
Isoantibodies
-
Isoantigens
-
Oligosaccharides
-
Oligosaccharides, Branched-Chain
-
Trisaccharides
-
blood group A trisaccharide
-
blood group B trisaccharide